[1]
Setina, M. et al. 2025. Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma. Radiology and Oncology. 59, 3 (Sep. 2025), 403–411.